Loading...
•
Mar 31, 2020
Artivion Q1 2020 Earnings Report
Reported a decrease in total revenues and a net loss for the first quarter of 2020.
Key Takeaways
CryoLife reported a decrease in total revenues by 2% to $66.4 million for the first quarter of 2020. The company experienced a net loss of $6.7 million, or $0.18 per share, compared to a net loss of $0.3 million, or $0.01 per share, in the first quarter of 2019. Growth in tissue processing and On-X revenues was offset by decreases in BioGlue and JOTEC revenues.
Total revenues reached $66.4 million, a 2% decrease compared to Q1 2019.
Excluding TMR, total revenues increased 1% versus first quarter of 2019
Net loss was ($6.7) million, or ($0.18) per fully diluted common share
Non-GAAP net loss was ($3.0) million, or ($0.08) per fully diluted common share
Forward Guidance
CryoLife withdrew its 2020 financial guidance due to uncertainties resulting from the COVID-19 pandemic.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...